{"filing":{"accession_number":"0001493152-26-032762","cik":"0002004489","ticker":"BMGL","company_name":"Basel Medical Group Ltd","form":"6-K","filing_date":"2026-07-10","report_date":null,"primary_document":"form6-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2004489/000149315226032762/form6-k.htm"},"events":[{"id":16952,"run_id":15176,"accession_number":"0001493152-26-032762","anchor_item_number":"EX-99.1","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"The exhibit announces that Basel Medical Group has regained compliance with Nasdaq's minimum bid price rule (Listing Rule 5550(a)(2)) after receiving a non-compliance notice on January 22, 2026. The company's shares had fallen below the $1.00 minimum bid price threshold but have now maintained $1.00 or greater for 10 consecutive business days. This disclosure directly addresses a delisting risk — the company was previously out of compliance with a continued listing standard and has now cured that deficiency. Material to investors as it resolves an immediate threat to continued listing on Nasdaq.","company_name":"Basel Medical Group Ltd","ticker":"BMGL","filing_date":"2026-07-10","form":"6-K","submitted_at":null,"items":[{"id":15217,"accession_number":"0001493152-26-032762","item_number":"EX-99.1","item_title":"ex99-1.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The exhibit announces that Basel Medical Group has regained compliance with Nasdaq's minimum bid price rule (Listing Rule 5550(a)(2)) after receiving a non-compliance notice on January 22, 2026. The company's shares had fallen below the $1.00 minimum bid price threshold but have now maintained $1.00 or greater for 10 consecutive business days. This disclosure directly addresses a delisting risk — the company was previously out of compliance with a continued listing standard and has now cured that deficiency. Material to investors as it resolves an immediate threat to continued listing on Nasdaq.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-10T11:01:41.384980+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":15217,"accession_number":"0001493152-26-032762","item_number":"EX-99.1","item_title":"ex99-1.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The exhibit announces that Basel Medical Group has regained compliance with Nasdaq's minimum bid price rule (Listing Rule 5550(a)(2)) after receiving a non-compliance notice on January 22, 2026. The company's shares had fallen below the $1.00 minimum bid price threshold but have now maintained $1.00 or greater for 10 consecutive business days. This disclosure directly addresses a delisting risk — the company was previously out of compliance with a continued listing standard and has now cured that deficiency. Material to investors as it resolves an immediate threat to continued listing on Nasdaq.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-10T11:01:41.384980+00:00","company_name":"Basel Medical Group Ltd","ticker":"BMGL","filing_date":"2026-07-10"}]}